Tackling our “drive to prescribe”
Members of the Lown Institute Working Group on Medication Overload gave a webinar presentation last week, which is available to watch now! More
Blog
Covid-19 puts more pressure on state budgets
State budgets have been squeezed over the past decade due in large part to the rising cost of health care, and Covid-19 is only making it worse. What can we do about this problem? More
PRESS RELEASE: Can 2020 Push Hospitals From Good To Great?
The new Lown Institute Hospitals Index assesses civic leadership, value, and outcomes at US Hospitals. More
The harms and benefits of blood thinners for older adults
In the latest edition of the American Family Physician's Right Care Series, doctors and patients discuss the benefits and harms of taking anticoagulants for atrial fibrillation in older adults. More
Bias in clinical algorithms make health disparities worse
A recent study from NEJM shows how inequality is “baked into the system” through clinical algorithms. More
Remdesivir report sparks more debate on drug price value
How much should remdesivir cost? This question puts two drug-value organizations at odds. More
Video: Science’s Viral Misinformation
Watch the video of Shannon Brownlee and Jeanne Lenzer discussing pandemic misinformation in a Future Tense conversation. More
Paying attention to the mental health effects of lockdown
Even though we have saved lives by locking down, we still have to address the effects of this decision on our country's mental health. More
Pharma sales reps still visiting doctors in the pandemic
Visits from pharmaceutical sales reps haven't stopped during the pandemic--they've just moved online... More
Guest Blog: Is GRAIL the “holy grail” of cancer screening?
From Dr. Ronald Adler, why we should be wary of the promises of GRAIL and other liquid biopsy companies. More